What is Nipah virus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Nipah Virus?

Nipah virus (NiV) is a highly lethal zoonotic paramyxovirus transmitted primarily from fruit bats to humans, causing severe encephalitis and respiratory disease with case fatality rates of 40-75%, and is capable of human-to-human transmission. 1, 2, 3

Viral Classification and Structure

  • NiV is a biosafety level-4 pathogen belonging to the genus Henipavirus within the Paramyxoviridae family 1, 4
  • The virus has a pleomorphic structure with a single-stranded negative-sense RNA genome encoding six structural proteins and three nonstructural proteins 3
  • Two major genetic clades exist: NiV-MY (Malaysia/Cambodia strains) and NiV-BD (Bangladesh/India strains), with differing clinical and epidemiological features 4, 5

Natural Reservoir and Transmission

  • Pteropid fruit bats (flying foxes), particularly Pteropus species, serve as the natural reservoir hosts without developing disease 1, 2, 4
  • Transmission occurs through multiple routes: bat-to-human via contaminated fruit or bat saliva/excrement, pig-to-human during outbreaks involving livestock, and critically, human-to-human transmission in approximately 50% of cases 1, 6, 2
  • The secondary attack rate among household contacts is extraordinarily high at approximately 50%, far exceeding diseases like meningococcal infection (4 per 1,000 contacts) 6
  • Intermediate hosts include pigs, horses, and domestic animals, with pigs serving as amplifying hosts particularly in Malaysian outbreaks 1, 2, 7

Clinical Manifestations

  • Initial presentation includes fever, headache, altered mental status, dizziness, and vomiting 1
  • Neurological features are prominent: myoclonus with characteristic 1:1 relationship to EEG periodic complexes, dystonia, areflexia, and hypotonia indicate severe CNS involvement and poor prognosis 1, 8
  • Respiratory manifestations include pneumonitis and severe respiratory illness, particularly in Bangladesh/India strains 1, 2
  • MRI demonstrates discrete focal lesions throughout the brain, predominantly in subcortical and deep white matter of cerebral hemispheres 1
  • Case fatality rates range from 40-75% depending on healthcare availability, patient condition, and viral strain virulence 2, 3

Geographic Distribution and Epidemiology

  • First identified in Kampung Sungai Nipah village, Malaysia in 1998 during an outbreak among pig farmers 1, 4
  • Subsequent outbreaks reported in Singapore (1999), Bangladesh, India, and the Philippines 1, 2
  • The disease is endemic to South and Southeast Asia, with recurrent outbreaks particularly in Bangladesh and India 2, 5, 7
  • Transmission patterns vary geographically based on breeding methods, eating habits, and viral strain characteristics 2

Diagnosis

  • Serological testing detects antibodies but may show cross-reactivity with other paramyxoviruses 1
  • CSF culture and PCR are diagnostic, though CSF culture sensitivity varies 1
  • Molecular methods using RT-PCR from respiratory specimens, throat swabs, and CSF provide specific diagnosis 4, 7
  • Multiple enzyme-linked immunosorbent assays have been developed for diagnostic and surveillance purposes 4
  • Contact with the CDC Special Pathogens Branch is recommended for suspected cases 1

Treatment and Management

  • Supportive care remains the cornerstone of treatment, as no proven effective antiviral therapy exists 1, 8, 5
  • Ribavirin has been used investigationally with C-III level evidence, though efficacy remains limited 1, 8
  • Early intubation and invasive mechanical ventilation are recommended over prolonged non-invasive ventilation trials in severe hypoxemia, as delays worsen outcomes and increase healthcare worker exposure risk 8
  • ICU-level monitoring with continuous assessment of vital signs, oxygen saturation, neurological status, and organ function is mandatory 8
  • Aggressive anticonvulsant therapy with continuous EEG monitoring is required for myoclonic seizures and status epilepticus 8
  • Nutritional support with high-protein, high-vitamin diets for stable patients, and early enteral or parenteral nutrition for critically ill patients 8

Infection Control

  • Healthcare workers must use airborne precautions with N-95 respirators, gowns, aprons, and face shields due to the high risk of nosocomial transmission 8
  • Strict biosecurity measures are essential given the 50% secondary attack rate among close contacts 6
  • Rapid outbreak detection and implementation of infection control measures are critical for containment 5, 7

Public Health Significance

  • The WHO has categorized NiV as a priority pathogen due to its epidemic potential, recurrent outbreaks, and alarming mortality rates 3
  • The worldwide distribution of fruit bat reservoirs means potential spillover events cannot be dismissed in new geographic areas 2
  • Climate change and anthropogenic habitat modifications may influence bat ecology and increase spillover risk 2, 3
  • No licensed vaccines or therapeutics are currently available, though several candidates are under development 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nipah virus infection: A review.

Epidemiology and infection, 2019

Guideline

Nipah Virus Transmission and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Nipah Virus Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.